Cargando…
Engineered cytokine/antibody fusion proteins improve delivery of IL-2 to pro-inflammatory cells and promote antitumor activity
Progress in cytokine engineering is driving therapeutic translation by overcoming the inherent limitations of these proteins as drugs. The interleukin-2 (IL-2) cytokine harbors great promise as an immune stimulant for cancer treatment. However, the cytokine’s concurrent activation of both pro-inflam...
Autores principales: | Leonard, Elissa K., Tomala, Jakub, Gould, Joseph R., Leff, Michael I., Lin, Jian-Xin, Li, Peng, Porter, Mitchell J., Johansen, Eric R., Thompson, Ladaisha, Cao, Shanelle D., Henclova, Tereza, Huliciak, Maros, Vaněk, Ondřej, Kovar, Marek, Leonard, Warren J., Spangler, Jamie B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187205/ https://www.ncbi.nlm.nih.gov/pubmed/37205604 http://dx.doi.org/10.1101/2023.05.03.539272 |
Ejemplares similares
-
Protein Binder (ProBi) as a New Class of Structurally Robust Non-Antibody Protein Scaffold for Directed Evolution
por: Pham, Phuong Ngoc, et al.
Publicado: (2021) -
Antibody–Invertase
Fusion Protein Enables Quantitative
Detection of SARS-CoV-2 Antibodies Using Widely Available Glucometers
por: Leonard, Elissa K., et al.
Publicado: (2022) -
Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices
por: Huličiak, Martin, et al.
Publicado: (2022) -
Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection
por: VanDyke, Derek, et al.
Publicado: (2022) -
IL-2/JES6-1 mAb complexes dramatically increase sensitivity to LPS through IFN-γ production by CD25(+)Foxp3(-) T cells
por: Tomala, Jakub, et al.
Publicado: (2021)